Tag: Kidney Problems: Misc.
Outcomes Examined for Primary Nephrotic Syndrome in Adults
Significant variation observed for risk for developing end-stage kidney disease according to etiology of nephrotic syndrome
Many at High Priority for Kidney Transplant Not on Waitlist
Nonlisted patients disproportionally African American, lack commercial insurance, or reside in lower-income communities
Hemodialysis Patients Have Antibody Response to COVID-19 Vaccine
But few kidney transplant recipients develop anti-spike SARS-CoV-2 antibodies after second mRNA vaccine dose
Smartphone App Improves Kidney Transplant Outcomes
Pharmacist-led intervention cuts medication errors and hospitalizations
Removing Race Adjustment Could Up Prevalence of CKD in Blacks
Some Black medication users reclassified to lower eGFR for which dose adjustment or discontinuation is recommended
Lower Kidney Function May Up Dementia Risk in Older Adults
In addition, steeper decline in eGFR within one year associated with higher dementia risk
Farxiga Approved to Reduce Risk for CKD Progression
SGLT2 inhibitor approved for patients with CKD to prevent kidney function decline, kidney failure, CV death, hospitalization for heart failure
Transient Improvement Found in Sedentary Time in CKD With Intervention
Maximum reduction in sedentary duration and increase in number of steps/day seen at week 20, attenuated by week 24
Digital App Cuts Meds Discrepancies in Outpatients With CKD
Patients in eKidneyCare group had fewer total medication discrepancies and a reduction in severity of discrepancies
2021 KDIGO Guideline Lowers Target Systolic BP for Adults With CKD
69.5 percent of adults with CKD eligible for BP lowering according to 2021 KDIGO guideline versus 49.8 percent with 2012 guideline
